• Subject matter details in previous versions

  Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
  Advocate for the adoption of innovative payer agreements at the pan-Canadian level that would incorporate real world evidence	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
  Advocate for workload capacity building and the acceleration of the work of the pan-Canadian Pharmaceutical Alliance which is an intergovernmental collaboration currently chaired by BC	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
  Budget 2026 preparation and submission discussion.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
  Discussion highlighting the contribution of IMC membership to health outcomes and economic sustainability in British Columbia, and advocating for provincial government policy initiatives and investment decisions (e.g., R&D commercialization incentives, infrastructure support) to support the life sciences sector as a driver of long-term economic growth in the province	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
  Discussion on the Pharmaceutical Care Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
  Engage with the BC government to advocate for greater access to innovative medicines and vaccines for British Columbians, supportive policies to attract research and development investment, and greater collaboration to build a stronger life sciences sector and a more sustainable health system.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
  PharmaCare budget, pharmaceutical listings and the Pharmaceutical Care Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
  Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations and their impact on patient access and economic growth in British Colombia	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health, Intellectual Property, International Relations, International Trade, Science and Technology
  Budget 2025 preparation and submission discussion.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
  Introductory meeting, update on life sciences strategy, life sciences sector value to BC in health and economic recovery.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
  Introductory meeting – we spoke about IMC and our members value to BC in health and economic recovery.	Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to transfer from the Crown for consideration all or part of, or any interest in or asset of, any business, enterprise or institution that provides goods or services to the Crown, a Provincial entity or the public Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly	Health
  life sciences sector	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

Gifts or benefits provided by the organization